Ukraine plans to ban drug imports from Russia

13 November 2014

The Ukrainian government is considering imposing a ban on the import of drugs from Russia. This comes as a response to economic sanctions that were recently imposed by Russia on some Ukrainian goods.

According to Oleg Musy, Ukraine’s Minister of Health, as part of these plans the government may refuse further purchases of up to 300 Russian drugs. However, it is planned that Ukraine will continue imports of only 20 drugs from Russia, which have no analogues in Ukraine.

In the meantime, according to commentators at the Russian Ministry of Trade, the latest initiative of the Ukrainian government is the result of a pressure of some leading Ukrainian pharmaceutical producers, which plan to neutralize Russian rivals on the market and to significantly increase prices for their ranges.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >